Hepatitis C and insulin resistance: mutual interactions. A review (Q36839533)

16 August 2017

1 reference

title

Hepatitis C and insulin resistance: mutual interactions. A review (English)

1 reference

16 August 2017

1 reference

S Decock

1

1 reference

PubMed ID

17547292

16 August 2017

C Verslype

series ordinal

2

1 reference

PubMed ID

17547292

16 August 2017

J Fevery

series ordinal

3

1 reference

16 August 2017

1 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

62

1 reference

16 August 2017

2

1 reference

16 August 2017

111-119

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

16 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Endocrine and signalling role of adipose tissue: new perspectives on fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Review article: adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

To eat or not to eat - how the gut talks to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Fibrogenic impact of high serum glucose in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Putting the brakes on insulin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

Invited review: Exercise training-induced changes in insulin signaling in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.019

21 January 2018

Identifiers

DOI

10.1179/ACB.2007.019

1 reference

16 August 2017

1 reference

PubMed ID

17547292